Evidence map›Paper›PMID 42569693›Full record

ArticleCureus2026

When Clopidogrel Reaches the Lung: A Case of Diffuse Interstitial Lung Disease.

Emane Mengue Phalex, Darius Mbina Nzienghi, Laktib Nabil, Najoua Mouina, Marwane Ouhadi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emane Mengue PhalexDepartment of Cardiology, Military Teaching Hospital Mohammed V, Rabat, MAR.
Darius Mbina NzienghiDepartment of Emergency Medicine, Military Teaching Hospital Mohammed V, Rabat, MAR.
Laktib NabilDepartment of Cardiology, Military Teaching Hospital Mohammed V, Rabat, MAR.
Najoua MouinaDepartment of Cardiology, Rabat-Salé University Hospital Center, Rabat, MAR.
Marwane OuhadiDepartment of Radiology, Military Teaching Hospital Mohammed V, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced diffuse interstitial lung diseases are uncommon but potentially severe adverse reactions. Clopidogrel, a widely used antiplatelet agent for the prevention of thromboembolic events, has only rarely been associated with interstitial lung injury. We report the case of a 76-year-old former smoker with a history of dyslipidemia and triple-vessel coronary artery disease who was admitted for chest pain following a recent myocardial infarction. Coronary angiography revealed no new coronary lesions, and antiplatelet therapy was switched from ticagrelor to clopidogrel. Three days after clopidogrel initiation, the patient developed progressive dyspnea (New York Heart Association: NYHA class III), hypoxemia (partial pressure of oxygen or PaO

Indexed as

adverse drug reactionantiplatelet agentscase reportclopidogreldiffuse interstitial lung diseasedrug-induced lung diseasedrug-induced lung injurydrug-induced pneumonitisdyspneapulmonary toxicity

Identifiers

PMID42569693
PMCPMC13450797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.